Zachary Scheiner
Independent DirectorDr. Zachary Scheiner, also known as Zach, P.hD., is Director of Memento Medicines, Inc. Dr. Scheiner is Partner on the Investment Team of RA Capital Management, L.P. Dr. Scheiner serves as an Independent Director since July 2023 at SpyGlass Pharma, Inc. Dr. Scheiner was Principal of RA Capital Management, L.P. Dr. Scheiner was Independent Director of LENZ Therapeutics, Inc. from October 2020 to June 30, 2026. Dr. Scheiner is Director of Sydnexis, Inc. Dr. Scheiner is Independent Director of Nkarta, Inc. from February 2020. Dr. Scheiner is Director of Sparrow Pharmaceuticals, Inc. from September 2025. Dr. Scheiner is Director of SpyGlass Pharma, Inc. Dr. Scheiner is Director of SpyGlassPharma, Inc. Dr. Scheiner was Director of Adagio Medical Holdings, Inc. until November 10, 2023. Dr. Scheiner was employed at Adagio Medical Holdings, Inc. until November 10, 2023. Dr. Scheiner was Director of Exo Imaging, Inc. Dr. Scheiner has Ph.D. in Neurobiology from University of Washington in 2007, B.S. in Biochemistry & Molecular Biophysics from Yale University in 1997.
Positions
- Company NameNkarta, Inc.Stock CodeNKTXPositionIndependent DirectorColleagues
- PJPaul J. HastingsCEO & Director
- ABAli BehbahaniIndependent Chairman
- NMNadir MahmoodPresident and Principal Accounting & Financial Officer
- SRShawn RoseChief Medical Officer and Head of Research & Development
- MPMichael Philip DybbsIndependent Director
- LDLeone D. PattersonIndependent Director
- ZSZachary ScheinerIndependent Director
- Company NameSpyGlass Pharma, Inc.Stock CodeSGPPositionIndependent DirectorColleagues
- MYMalik Y. KahookCo-Founder, President, Chief Medical Officer & Executive Chairman
- PHPatrick H. MooneyCEO & Director
- CPChetan PujaraChief Research & Development Officer
- GSGlenn SussmanCo-founder & Chief Technology Advisor
- JVJean-Frederic ViretChief Financial Officer
- BABilal Arshad KhanIndependent Director
- EGElizabeth G. O’FarrellIndependent Director
